Q-linea, a recent spin-out of Swedish biotechnology company Olink Bioscience, last week said its first corporate goal is to develop a flow cytometry-based field-deployable detection system for biodefense applications that will eventually work together with microarrays.
 
“One option we are discussing right now is to have Q-linea as an early-stage platform and then you could have detection performed on an array at a later stage,” CEO Jonas Jarvius told BioArray News this week.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.